Disclosures Prof. C.Pozzilli

Has served on scientific advisory boards for Novartis, Merck Serono, Biogen, Sanofi-Genzyme, Roche, Alexion, Bristol Myers, Almirall and Actelion and has received funding for travel and speaker honoraria from Novartis, Merck Serono, Biogen, Sanofi-Genzyme, Roche, Actelion, Almirall, Alexion, and receives research support from Merck Serono, Biogen Idec, Roche and Almirall.

Cognition in MS: a marker of silent progression

'At a certain stage of the disease, patients with MS may show marked enfeeblement of the memory; conceptions are formed slowly (information processing speed); the intellectual and emotional faculties are blunted in their entirety‘

(1877) lectures on the diseases of the nervous system, London

Cognition in MS: a marker of silent progression